Age 0 3 0 3 B-age
> 4 5 4 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound

Cr 0 2 15 17 B-clinical_variable
> 3 4 18 19 O
2.0 4 7 19 22 B-lower_bound

For 0 3 23 26 O
patients 4 12 27 35 O
undergoing 13 23 36 46 O
research 24 32 47 55 O
only 33 37 56 60 O
biopsy 38 44 61 67 B-treatment
: 44 45 67 68 O
Requirement 46 57 69 80 O
for 58 61 81 84 O
anticoagulation 62 77 85 100 B-treatment
with 78 82 101 105 I-treatment
heparin 83 90 106 113 I-treatment
, 90 91 113 114 O
low 92 95 115 118 B-treatment
molecular 96 105 119 128 I-treatment
weight 106 112 129 135 I-treatment
heparin 113 120 136 143 I-treatment
, 120 121 143 144 O
clopidogrel 122 133 145 156 B-treatment
, 133 134 156 157 O
rivaroxaban 135 146 158 169 B-treatment
, 146 147 169 170 O
dabigatran 148 158 171 181 B-treatment
, 158 159 181 182 O
apixaban 160 168 183 191 B-treatment
, 168 169 191 192 O
warfarin 170 178 193 201 B-treatment
, 178 179 201 202 O
Aggrenox 180 188 203 211 B-treatment
, 188 189 211 212 O
fondaparux 190 200 213 223 B-treatment
, 200 201 223 224 O
ticagrelor 202 212 225 235 B-treatment
, 212 213 235 236 O
etc 214 217 237 240 O
( 218 219 241 242 O
aspirin 219 226 242 249 B-treatment
and 227 230 250 253 O
other 231 236 254 259 O
NSAIDs 237 243 260 266 B-treatment
are 244 247 267 270 O
ok 248 250 271 273 O
but 251 254 274 277 O
should 255 261 278 284 O
be 262 264 285 287 O
held 265 269 288 292 O
prior 270 275 293 298 O
to 276 278 299 301 O
biopsy 279 285 302 308 O
in 286 288 309 311 O
accordance 289 299 312 322 O
with 300 304 323 327 O
institutional 305 318 328 341 O
standard 319 327 342 350 O
of 328 330 351 353 O
care 331 335 354 358 O
) 335 336 358 359 O

Histologically 0 14 360 374 O
confirmed 15 24 375 384 O
diagnosis 25 34 385 394 O
of 35 37 395 397 O
adenocarcinoma 38 52 398 412 B-cancer
of 53 55 413 415 I-cancer
the 56 59 416 419 I-cancer
prostate 60 68 420 428 I-cancer

History 0 7 429 436 O
of 8 10 437 439 O
intercurrent 11 23 440 452 O
or 24 26 453 455 O
past 27 31 456 460 O
medical 32 39 461 468 O
or 40 42 469 471 O
psychiatric 43 54 472 483 B-chronic_disease
illness 55 62 484 491 I-chronic_disease
that 63 67 492 496 O
would 68 73 497 502 O
make 74 78 503 507 O
participation 79 92 508 521 O
in 93 95 522 524 O
a 96 97 525 526 O
research 98 106 527 535 O
biopsy 107 113 536 542 O
protocol 114 122 543 551 O
difficult 123 132 552 561 O
or 133 135 562 564 O
not 136 139 565 568 O
feasible 140 148 569 577 O
at 149 151 578 580 O
the 152 155 581 584 O
discretion 156 166 585 595 O
of 167 169 596 598 O
the 170 173 599 602 O
principal 174 183 603 612 O
investigator 184 196 613 625 O
or 197 199 626 628 O
co 200 202 629 631 O
- 202 203 631 632 O
investigator(s 203 217 632 646 O
) 217 218 646 647 O

Platelets 0 9 648 657 B-clinical_variable
â‰¥ 10 11 658 659 O
100,000 12 19 660 667 B-lower_bound

Radiographic 0 12 668 680 O
evidence 13 21 681 689 O
of 22 24 690 692 O
at 25 27 693 695 O
least 28 33 696 701 O
one 34 37 702 705 B-lower_bound
bone 38 42 706 710 B-cancer
, 42 43 710 711 O
lymph 44 49 712 717 B-cancer
node 50 54 718 722 I-cancer
, 54 55 722 723 O
or 56 58 724 726 O
liver 59 64 727 732 B-cancer
metastasis 65 75 733 743 I-cancer
, 75 76 743 744 O
that 77 81 745 749 O
is 82 84 750 752 O
amenable 85 93 753 761 O
to 94 96 762 764 O
iodinated 97 106 765 774 O
contrast 107 115 775 783 O
injection 116 125 784 793 O
, 125 126 793 794 O
as 127 129 795 797 O
judged 130 136 798 804 O
by 137 139 805 807 O
the 140 143 808 811 O
study 144 149 812 817 O
radiologist 150 161 818 829 O

Small 0 5 830 835 B-cancer
cell 6 10 836 840 I-cancer
or 11 13 841 843 I-cancer
neuroendocrine 14 28 844 858 I-cancer
tumors 29 35 859 865 I-cancer
of 36 38 866 868 I-cancer
the 39 42 869 872 I-cancer
prostate 43 51 873 881 I-cancer
are 52 55 882 885 O
also 56 60 886 890 O
permitted 61 70 891 900 O

